Collaborative Synthesis for Neglected Diseases through the Open Synthesis Network: Structure-Activity Relationships of Arylaminopyrazoles as Chagas Disease Treatments.
Abdulai Z, Agbo N, Anderson JI, Astley F, Chan B, Atkinson-Evans O, Avelar JL, Aparecida-Silva C, Bhardwaj KD, Bowley WJ, Breitkreuz N, Canby R, Cartwright E, Clifford C, Cordell SA, Donker WJ, Driscoll J, Grady M, Higginbotham L, Hsu D, Hutchinson J, Imberg L, Jackson HF, Johns F, Jones E, Kalinin DV, Kardeşler C, Keal A, Keel L, Kim S, Knight P, Ködel JF, Kumeta L, Lee H, Le Roy S, Maccarone R, Mahmud M, Martin M, Nguyen I, Nolan CJ, Noyes L, Ntuwa ANW, Obarska W, Oldham O, Onyiuke E, Otter J, Page H, Patel D, Reid K, Samaddar K, Shabbir SM, Shevlin P, Sinclair-Wright C, Smithies A, Thomson AS, Tinker J, Uner A, Van Pelt N, Waddell E, Wagwa H, Walthorne C, Warner S, Winge T, Sum Wong N, Wysocki LJ, Yong CA, Zaheen Z, Matheeussen A, Caljon G, Amewu R, Bertram A, Biersack B, Friel C, Lima LM, Smith C, Wünsch B, Perry B, Cruz LR, Nortcliffe A.
Abdulai Z, et al. Among authors: warner s.
ACS Infect Dis. 2025 Aug 11. doi: 10.1021/acsinfecdis.5c00481. Online ahead of print.
ACS Infect Dis. 2025.
PMID: 40788996